Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Shea

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of the National Cancer Institute|March 24, 2025
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patientsPhilip C Mack, James M Crawford, Andres Chang, et al.
Vaccine|July 4, 2021
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in ZambiaJohn Mwaba, Caroline Cleopatra Chisenga, Shaoming Xiao, et al.
Research Square|November 28, 2023
Application of machine learning models to identify serological predictors of COVID-19 severity and outcomesSabra Klein, Santosh Dhakal, Anna Yin, et al.
Human Molecular Genetics|December 30, 2025
Phenotypic expansion of CALM1/2-associated disorders to include neurologic phenotypes without arrhythmiaHieu D Hoang, Rebecca C Spillmann, Daniel J Wegner, et al.
Communications Medicine|November 26, 2024
Application of machine learning algorithms to identify serological predictors of COVID-19 severity and outcomesSantosh Dhakal, Anna Yin, Marta Escarra-Senmarti, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of the National Cancer Institute|March 24, 2025
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patientsPhilip C Mack, James M Crawford, Andres Chang, et al.
Vaccine|July 4, 2021
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in ZambiaJohn Mwaba, Caroline Cleopatra Chisenga, Shaoming Xiao, et al.
Research Square|November 28, 2023
Application of machine learning models to identify serological predictors of COVID-19 severity and outcomesSabra Klein, Santosh Dhakal, Anna Yin, et al.
Human Molecular Genetics|December 30, 2025
Phenotypic expansion of CALM1/2-associated disorders to include neurologic phenotypes without arrhythmiaHieu D Hoang, Rebecca C Spillmann, Daniel J Wegner, et al.
Communications Medicine|November 26, 2024
Application of machine learning algorithms to identify serological predictors of COVID-19 severity and outcomesSantosh Dhakal, Anna Yin, Marta Escarra-Senmarti, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Pageof 3